Lakefront Biotherapeutics (LKFT) Drug Pipeline

The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness

A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.

Lakefront Biotherapeutics LKFT is currently developing the following drugs: Glpg Car T-Cell Therapy, Glpg5101, Filgotinib, Glpg3667, Glpg3667 Capsule, [14C]-Glpg3667 Solution For Infusion, [14C]-Glpg3667 Capsule, Itraconazole, Glpg3667, Midazolam, Glpg4716, Glpg4716, Nintedanib, Pirfenidone, Glpg3970 Film-Coated Tablet, [14C]Glpg3970 Solution For Infusion, [14]Glpg3970 Oral Solution, Glpg3121, Midazolam, Glpg3667, Sulfasalazine, Glpg3970, Glpg1205 Film-Coated Tablets, [14C]-Glpg1205 Solution For Infusion, Glpg1205 Capsules, Glpg3970 Oral Solution, Glpg3970 Tablet, Glpg3970 Film-Coated Tablet, Glpg3970, Glpg4399 Oral Suspension, Glpg4399 Capsules, Rosuvastatin, Atorvastatin, Pravastatin, Filgotinib, Glpg2737, Glpg4059 Oral Suspension, Glpg4059 Tablet, Glpg1205, Glpg1972 - A, Glpg1972 - B, Glpg1972 - C, Glpg1972 Film-Coated Tablets, [14C]-Glpg1972 Solution For Infusion, [14C]-Glpg1972 Oral Solution, Adalimumab, Filgotinib, Glpg3970 Oral Solution, Glpg3970 Capsule, Glpg3667 Oral Suspension, Glpg3667 Capsules, Glpg1690, Standard of Care, Filgotinib, Glpg3121 Sad, Glpg3121 Mad, Mor106, Glpg3312 Ir, Glpg3312 Mr, Glpg3312 Fe Mr. These drug candidates are in various stages of clinical development as the company works toward FDA approval.